Luxist Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Eli Lilly and Company - Wikipedia

    en.wikipedia.org/wiki/Eli_Lilly_and_Company

    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

  3. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

    www.aol.com/news/eli-lilly-lifts-profit-view...

    Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...

  4. Eli Lilly and Co., increases LEAP District investment to $9B ...

    www.aol.com/eli-lilly-co-increases-leap...

    May 24, 2024 at 1:11 PM. Eli Lilly and Co., is more than doubling its investment in its Boone County manufacturing site to increase production of ingredients in its blockbuster weight loss and ...

  5. Is Eli Lilly's Latest Deal a Gamechanger? - AOL

    www.aol.com/finance/eli-lillys-latest-deal-game...

    Eli Lilly recently announced that it is acquiring an injectable manufacturing facility from Nexus Pharmaceuticals. For now, GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are ...

  6. Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 ...

    www.aol.com/finance/eli-lilly-reports-2-billion...

    Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023. Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024 [Video ...

  7. Lilly exec eyes more weight-loss drug launches this year - AOL

    www.aol.com/news/lilly-exec-says-supply...

    By Divya Chowdhury and Patrick Wingrove. DAVOS, Switzerland (Reuters) -Eli Lilly on Tuesday said it plans to launch its weight-loss drug Mounjaro in new countries this year as it expands ...

  8. Eli Lilly CFO: Weight-loss drug demand will outstrip GLP-1 ...

    www.aol.com/finance/eli-lilly-cfo-weight-loss...

    Eli Lilly shares were down slightly Tuesday despite reporting better-than-expected earnings on both the top and bottom lines for the final quarter of 2023, driven by an expected boost from GLP-1 ...

  9. Eli Lilly: Positive results on its new Alzheimer's drug - AOL

    www.aol.com/finance/eli-lilly-positive-results...

    Eli Lilly stock closed up 6.68% to $431.19 on Wednesday. There is, however, some concern among experts. Two patients died from the drug, and a third died during the clinical trials, the company said.